Skip to content

Clinical trials

Lung Diseases trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Country / region: Canada Clear all

98 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20042
20051
20063
20073
20081
20096
20103
20114
20122
20135
20144
20156
20166
20177
20185
20199
20206
20214
20222
20235
20246
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed59
Recruiting15
Active, not recruiting8
Terminated8
Unknown status5
Enrolling by invitation2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca17
University of British Columbia5
Eli Lilly and Company4
Vertex Pharmaceuticals Incorporated4
Novartis Pharmaceuticals3
University Health Network, Toronto3
University of Alberta3
Blueprint Medicines Corporation2
McMaster University2
Taiho Oncology, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases98
Respiratory Tract Diseases41
Lung Neoplasms19
Asthma18
Bronchial Diseases17
Carcinoma, Non-Small-Cell Lung16
Cystic Fibrosis14
Lung Diseases, Obstructive13
Neoplasms13
Pulmonary Disease, Chronic Obstructive12

Trials

Showing 1 to 25 of 98. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.